Thrombin, an ideal target for pharmacological inhibition: A review of direct thrombin inhibitors
- 31 January 2005
- journal article
- review article
- Published by Elsevier in American Heart Journal
- Vol. 149 (1), S43-S53
- https://doi.org/10.1016/j.ahj.2004.10.022
Abstract
No abstract availableThis publication has 80 references indexed in Scilit:
- Heparin-induced thrombocytopeniaJournal of Thrombosis and Haemostasis, 2003
- Decreased platelet reactivity in blood anticoagulated with bivalirudin or enoxaparin compared with unfractionated heparin: implications for coronary intervention.Journal of Thrombosis and Thrombolysis, 2002
- Attenuation of Rebound Ischemia After Discontinuation of Heparin Therapy by Glycoprotein IIb/IIIa Inhibition With Eptifibatide in Patients With Acute Coronary SyndromesCirculation, 2001
- Platelet Activation With Unfractionated Heparin at Therapeutic Concentrations and Comparisons With a Low-Molecular-Weight Heparin and With a Direct Thrombin InhibitorCirculation, 1998
- Heparin neutralization by platelet-rich thrombi. Role of platelet factor 4.Circulation, 1994
- Reactivation of Unstable Angina after the Discontinuation of HeparinNew England Journal of Medicine, 1992
- HeparinNew England Journal of Medicine, 1991
- Clot-bound thrombin is protected from inhibition by heparin-antithrombin III but is susceptible to inactivation by antithrombin III-independent inhibitors.Journal of Clinical Investigation, 1990
- Monocyte Chemotaxis: Stimulation by Specific Exosite Region in ThrombinScience, 1983
- Chemotactic response of monocytes to thrombin.The Journal of cell biology, 1983